Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.22.1
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Schedule of accrued liabilities [Abstract]    
Accrued labor costs $ 691  
Accrued drug development costs 369
Other 152 168
Total $ 1,212 $ 168